Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
bortezomib (velcade) (1 trial)
mycophenolate (CellCept) (1 trial)
Uremia (Phase 2)
Trials (1 total)
Trial APIs (2 total)